436091-70-2

Upstream product

• 95201-27-7 (2S,3S)-[1-(trityloxy)-but-2-ene oxide] 
• 436091-67-7 4-bromo-1-(tert-butyl-dimethyl-silanyl)-7-methoxy-1H-indole 
• 436091-59-7 4-bromo-7-methoxy-1H-indole 
• 108-39-4 3-methyl-phenol 
• 85598-13-6 1-bromo-4-methoxy-2-methyl-3-nitro-benzene 
• 85598-12-5 4-bromo-3-methyl-2-nitro-phenol 
• 4920-77-8 3-methyl-2-nitrophenol 

Downstream Products

• 436092-17-0 (2R,3S)-3-(7-Methoxy-1H-indol-4-yl)-1-trityloxy-butan-2-ol 
• 436093-34-4 (2R,3S)-3-[7-Methoxy-1-(toluene-4-sulfonyl)-1H-indol-4-yl]-1-trityloxy-butan-2-ol 
• 436091-30-4 N-(5-{1-[7-methoxy-1-(toluene-4-sulfonyl)-1H-indol-4-yl]-ethyl}-1H-imidazol-2-yl)-acetamide 
• 436097-24-4 methanesulfonic acid 3-[7-methoxy-1-(toluene-4-sulfonyl)-1H-indol-4-yl]-2-oxo-butyl ester 
• 436093-85-5 1-hydroxy-3-[7-methoxy-1-(toluene-4-sulfonyl)-1H-indol-4-yl]-butan-2-one 
• 436097-25-5 1-bromo-3-[7-methoxy-1-(toluene-4-sulfonyl)-1H-indol-4-yl]-butan-2-one 

Relevant academic research and scientific papers

Enantioselective synthesis of the aminoimidazole segment of dragmacidin D

A facile enantioselective synthesis of the 2-aminoimidazole side-chain of dragmacidin D has been developed, which involved the regio- and stereoselective opening of the chiral epoxide 9 by a diindolylcuprate reagent, followed by further steps to give 5-substituted N-(1H-imidazol-2-yl)acetamide 2.